Novalung Academy moved

Collaboration of the Novalung Academy and the University Hospital Frankfurt will be intensified

After the successful relocation of the Novalung headquarters in summer 2008 to Talheim/Germany, the Novalung Academy now also moved from Offenbach to Talheim.

Due to the relocation the Novalung Academy is able to intensify its cooperation with the University Hospital Frankfurt. So the theoretical part of the course “protective ventilation strategies” will take place in the congress center “Hoffmanns-Höfe” which is close to the University Hospital. The following practical training in the University Hospital Frankfurt is now easily reachable by foot in a few minutes. Future “HFOV workshops” will take place at the new location of the Academy in Talheim.

We still offer individual courses and specialist trainings in your clinic as you’re accustomed to.

To ensure a maximum learning success, the free of charge trainings are limited to small groups of 15 persons maximum. The demand of the Academy courses is very high therefore an early registration is recommended.

Further information on courses and contents you will find on the website www.novalung-academy.com.

You can download high-resolution pictures as well as the literature compendium on www.novalung.com or it will be sent on request via email.

Please send us a copy of your imprint.

Background information Novalung GmbH - Driver of a paradigm shift

Novalung is the only company worldwide producing an artificial lung assist device – “Made in
Germany” - which breathes outside the patient. The iLA Membrane Ventilator® eliminates the carbon dioxide outside the human lung. It is driven by the human heart like a natural organ. Thereby the patient’s lung is protected as it doesn’t need to perform the complete gas exchange.

The iLA Membrane Ventilator® is implemented without surgery in a groin artery and vein by using two specifically developed NovaPort® vascular accesses. The artificial lung measures 14x14 cm only. Inside a hollow fibre membrane takes over the function of the pulmonary alveoli and completes the else wise common mechanical ventilation or can even replace it sometimes. Protective ventilation strategies can now be persecuted consequently; the natural lunge gets „time to heal“®. The iLA Membrane Ventilator® has been approved for a temporary use up to 29 days for patients of intensive care units.

In 2007 Novalung increased its portfolio by a high frequency oscillatory ventilator, Vision α®, being a quantum leap in mechanical ventilation. The high frequency oscillator focus on a very protective and efficient oxygenation and enables therefore an optimal combination with the iLA Membrane Ventilator® therapy.

Contact:

Franziska Preißing
Head of Marketing
franziska.preissing@novalung.com
Novalung GmbH
Egerten 3
D-74388 Talheim
Tel.: +49 7133 90 11 130
Fax: +49 7133 90 11 230
www.novalung.com

This release was published on openPR.